Cadrenal Therapeutics Advances Multi-Indication Strategy for CAD-1005; Launches Phase 2a Acute Kidney Injury (CSA-AKI) Clinical Plan to Accelerate Pharma Partnering at Upcoming BIO 2026

New high-value indication for Phase 3-ready asset with data intended to support clinical development and strategic partnering discussionsAdditional billion-dollar target- Cardiac Surgery-Associated Acute Kidney Injury (CSA-AKI), a serious complication affecting 35,000...

read more

Intelligent Protection Management Corp. to Participate in “Architecting Tomorrow: The AI Data Center Summit” Presented by Maxim Group LLC on Thursday, June 11th at 10:30 a.m. ET

JERICHO, NY / ACCESS Newswire / June 8, 2026 / Intelligent Protection Management Corp. ("IPM," "we," "us," "our" or the "Company") (NASDAQ:IPM), a managed technology solutions provider focused on enterprise cybersecurity and cloud infrastructure, announced today that...

read more
Skip to content